Effects of Oral Procaterol for Postinfectious Cough in Adults: SingleCentre, Randomized Double-Blind, Placebo-Controlled Trial

다국어 초록 (Multilingual Abstract)

Background: Persistent cough following an upper respiratory tract infection (URTI) is common in clinical practice.
We investigated the effects of procaterol on cough-specific quality of life (QoL) and peripheral-airway function among adults suffering from postinfectious cough (PIC).
Methods: This was a prospective, randomized, double-blinded placebo-controlled trial (NCT 02349919) conducted at a university hospital. Seventy-four non-asthmatic adults who had persistent post-URTI cough for ≥3 weeks were assessed by a physical examination, chest/paranasal sinus radiographs, spirometry, and impulse oscillometry (IOS) and were allocated to receive procaterol or placebo for 4 weeks. The Thai version of the Leicester Cough Questionnaire (LCQ-T), spirometry and IOS were assessed at baseline, 2 weeks, and 4 weeks.
Results: Mean LCQ-T total scores for the procaterol group (10.8) and placebo group (10.9) at baseline were not significantly different (P=0.821). After adjustment for baseline Borg Cough Scale score and post-nasal drip, the mean between-group difference was not significant for LCQ-T total score (-1.26; 95% confidence interval [CI], -2.69 to 0.17), physical domain score (-0.35; 95% CI, -0.76 to 0.06), psychological domain score (-0.53; 95% CI, -1.06 to 0.01), or social domain score (-0.38; 95% CI, -0.92 to 0.16). Large improvements in LCQ-T total score were reported in both groups after 2 weeks (procaterol, 4.21±2.73; placebo, 5.34±3.2), and 4 weeks (procaterol, 5.94±3.68; placebo, 7.07±3.44). No differences between groups were found in the mean changes of spirometry or IOS parameters after 4 weeks.
Conclusion: Our study shows that procaterol is not effective in the treatment of PIC, in terms of improvement of cough-specific QoL or peripheral-airway function.

참고문헌 (Reference)

1 Pornsuriyasak P, "Validity and reliability of the Thai version of the leicester cough questionnaire in chronic cough" 34 : 212-216, 2016

2 Suzuki H, "Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan" 1 : 175-183, 2013

3 Taramarcaz P, "Transient postviral vocal cord dysfunction" 114 : 1471-1472, 2004

4 Oostveen E, "The forced oscillation technique in clinical practice: methodology, recommendations and future developments" 22 : 1026-1041, 2003

5 Sekizawa K, "Role of substance P in cough during bronchoconstriction in awake guinea pigs" 151 : 815-821, 1995

6 Chonmaitree T, "Respiratory viruses induce production of histamine-releasing factor by mononuclear leukocytes:a possible role in the mechanism of virus-induced asthma" 164 : 592-594, 1991

7 Jirarattanaphochai K, "Reliability of the medical outcomes study short-form survey version 2.0(Thai version) for the evaluation of low back pain patients" 88 : 1355-1361, 2005

8 Volovitz B, "Release of leukotriene C4 in respiratory tract during acute viral infection" 112 : 218-222, 1988

9 Borson DB, "Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections" 66 : 2653-2658, 1989

10 Wang K, "Mycoplasma pneumoniae and respiratory virus infections in children with persistent cough in England: a retrospective analysis" 30 : 1047-1051, 2011

11 Pornsuriyasak P, "Minimal clinically important differences (MCIDs) of the thai version of the leicester cough questionnaire for subacute and chronic cough" 12 : 57-62, 2017

12 Empey DW, "Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection" 113 : 131-139, 1976

13 Hegele RG, "Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections" 151 : 1659-1664, 1995

14 Pornsuriyasak P, "Inhaled corticosteroid for persistent cough following upper respiratory tract infection" 10 : 520-524, 2005

15 Tomerak AA, "Inhaled beta2-agonists for treating non-specific chronic cough in children" CD005373-, 2005

16 Frank A, "Inhaled beclomethasone dipropionate in acute infections of the respiratory tract" 48 : 122-126, 1985

17 Crapo RO, "Guidelines for methacholine and exercise challenge testing-1999:this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999" 161 : 309-329, 2000

18 Ida S, "Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon" 145 : 892-906, 1977

19 Blair HT, "Effects of rhinovirus infection of pulmonary function of healthy human volunteers" 114 : 95-102, 1976

20 Dicpinigaitis PV, "Effect of viral upper respiratory tract infection on the urge-to-cough sensation" 105 : 615-618, 2011

21 Dicpinigaitis PV, "Effect of viral upper respiratory tract infection on cough reflex sensitivity" 6 : S708-S711, 2014

22 Tashimo H, "Effect of procaterol, a beta(2) selective adrenergic receptor agonist, on airway inflammation and hyperresponsiveness" 56 : 241-247, 2007

23 Fujimura M, "Effect of inhaled procaterol on cough receptor sensitivity to capsaicin in patients with asthma or chronic bronchitis and in normal subjects" 48 : 615-618, 1993

24 Busse WW, "Effect of influenza A virus on leukocyte histamine release" 71 : 382-388, 1983

25 Birring SS, "Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)" 58 : 339-343, 2003

26 Ryan NM, "Clinical and physiological features of postinfectious chronic cough associated with H1N1 infection" 106 : 138-144, 2012

27 Holmes PW, "Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection" 86 : 425-429, 1992

28 O’Connell F, "Capsaicin cough sensitivity increases during upper respiratory infection" 90 : 279-286, 1996

29 Salem H, "Antitussive drugs, with special reference to a new theory for the initation of the cough reflex and the influence or bronchodilators" 247 : 585-600, 1964

30 Hueston WJ, "A comparison of albuterol and erythromycin for the treatment of acute bronchitis" 33 : 476-480, 1991